A research agenda for malaria eradication: modeling
- PMID: 21283605
- PMCID: PMC3026697
- DOI: 10.1371/journal.pmed.1000403
A research agenda for malaria eradication: modeling
Abstract
Malaria modeling can inform policy and guide research for malaria elimination and eradication from local implementation to global policy. A research and development agenda for malaria modeling is proposed, to support operations and to enhance the broader eradication research agenda. Models are envisioned as an integral part of research, planning, and evaluation, and modelers should ideally be integrated into multidisciplinary teams to update the models iteratively, communicate their appropriate use, and serve the needs of other research scientists, public health specialists, and government officials. A competitive and collaborative framework will result in policy recommendations from multiple, independently derived models and model systems that share harmonized databases. As planned, modeling results will be produced in five priority areas: (1) strategic planning to determine where and when resources should be optimally allocated to achieve eradication; (2) management plans to minimize the evolution of drug and pesticide resistance; (3) impact assessments of new and needed tools to interrupt transmission; (4) technical feasibility assessments to determine appropriate combinations of tools, an associated set of target intervention coverage levels, and the expected timelines for achieving a set of goals in different socio-ecological settings and different health systems; and (5) operational feasibility assessments to weigh the economic costs, capital investments, and human resource capacities required.
Conflict of interest statement
No competing interests: PA, SE, SH, RS, DS, MT. AG has received payment for advice on malaria transmission modeling from Glaxo SmithKline (GSK). TS states that his research group is funded by the Bill & Melinda Gates Foundation and the Malaria Vaccine Initiative. He has no commercial interests that are relevant. LW states that she was on a malaria vaccine advisory board for GSK-Biologicals on 14–15 December 2009.
Figures

References
-
- Ross R. London: Waterlow and Sons Limited; 1908. Report on the prevention of malaria in Mauritius.
-
- Macdonald G. London; New York: Oxford University Press; 1957. The epidemiology and control of malaria.201
-
- WHO. Geneva: World Health Organization; 1957. Expert Committee on Malaria, sixth report. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials